Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,732.50
Bid: 1,732.50
Ask: 1,733.00
Change: 4.00 (0.23%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,736.50
Low: 1,729.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: SABMiller Accepts Improved AB InBev Offer

Tue, 13th Oct 2015 09:43

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.
----------
FTSE 100 - WINNERS
----------
SABMiller, up 9.0% at 3,946.50 pence. The Anglo-South African brewing giant has reached a deal to be acquired by larger rival Anheuser-Busch InBev, which increased its offer to GBP44 per share from GBP43.50 on day previously. A formal offer at that price would value SABMiller at GBP71.28 billion, with the combination of the two companies to create a global beer giant with a roughly GBP280 billion market cap. AB InBev now has until 1700 BST on October 28 to decide whether to make an firm offer or walk away.

GlaxoSmithKline, up 1.0% at 1,318.50 pence. JPMorgan upgraded the pharmaceutical company to Neutral from Underweight, and raised its price target to 1,370 pence from 1,320p.
----------
FTSE 100 - LOSERS
----------
Royal Mail, down 4.3% at 451.90 pence. The UK government said it has sold the majority of its 14% stake in Royal Mail PLC for around GBP591.0 million under an accelerated bookbuilding process announced the previous day. The government sold a 13% stake in Royal Mail, comprising around 130.0 million shares, at a placing price of 455.0 pence per share. The remaining 1% stake, equivalent to about 10.0 million shares, will be "gifted" to Royal Mail employees in the UK, marking the government's final disposal of shares.

Barclays, down 2.9%. The lender reportedly plans to name JPMorgan investment banker Jes Staley as its new chief executive, with confirmation to come in the next two weeks depending on regulatory approval. Such a move would put a high profile investment banker in charge at a time when there are big questions about the role of Barclays' investment banking division. Under the ousted Antony Jenkins, a retail banker, Barclays had set about reducing its overall reliance on the division as a source of earnings.

Glencore, down 5.4%. The commodities trader and mining company was down due to concerns about China's economy health. Anglo American, another miner, was down 3.3% and BHP Billiton down 2.0%. China's exports declined at a moderate pace in September as the devaluation of yuan helped it from falling sharply amid weak global demand. At the same time, imports plunged due to a drop in commodity prices and subdued domestic demand.
----------
FTSE 250 - WINNERS
----------
Bellway, up 3.5%. The housebuilder said it should be able to grow volumes by up to 10% in its current financial year, as it reported a 44% jump in pretax profit to GBP354.2 million in the year ended July 31 and raised its dividend to 77.0 pence from 52.0p.

Michael Page International, up 2.1%. The recruitment consultancy said Non-Executive Chairman Robin Buchanan plans to step down, as it reiterated its expectations for its full year. The company said its gross profit in the third quarter of 2015 rose 4.8% to GBP139.2 million from GBP132.9 million in the previous year. This growth was hit by volatility in foreign exchange rates, and at constant currency gross profit would have risen 10.2%.

Sophos Group, up 3.3% at 232.00 pence. Liberum initiated coverage of the security software and hardware developer at Buy with a 290p price target, saying the company has attractive cash dynamics and expects its earnings before interest, taxes, depreciation and amortisation to more than double over the next five years.
----------
FTSE 250 - LOSERS
----------
Weir Group, down 3.7% at 1,298.00 pence. The engineering company was hit by broker price-target cuts. Morgan Stanley cut its price target on Weir Group to 1,200 pence from 1,360p, and reiterated its Underweight rating. Meanwhile, UBS cut its price target on the company to 1,800p from 2,000p, and reiterated a Buy rating.
----------
MAIN MARKET AND AIM - WINNERS
----------
Flybe Group, up 6.6%. The airline on Tuesday boasted double-digit increases in seat capacity, passenger numbers and revenue in its second quarter, but reported a slight decline in passenger load factor.

Mediazest, up 34%. The audio-visual products company said it has secured new business worth a cumulative GBP1.0 million since announcing full-year results in August. It also had won new clients including Diesel SpA, Molson Coors Brewing Co and the John Lewis Partnership, and signed new business with existing clients, such as Hyundai Motor Co, Adidas AG and the Post Office Ltd.

RWS Holdings, up 18%. The patent translation and search company said it enjoyed a "significant" recovery in the second half of its last financial year, a boost after the flat sales performance in the opening six months of the year. The 2% increase in full-year sales, which reached GBP95.1 million, means the numbers were ahead of market expectations prior to the announcement.
----------
MAIN MARKET AND AIM - LOSERS
----------

Arrow Global, down 9.4% at 246.25 pence. Chief Executive Tom Drury, Chief Financial Officer Robert Memmott and other executives, together with an unnamed institutional investor, sold GBP27.5 million of shares in the debt manager. The 11 million shares were sold at 250 pence apiece overnight Monday to Tuesday. They represent a combined stake of 6.3%.

Galantas Gold Corp, down 14%. The company said that an individual intends to challenge its application for planning permission to allow the company to mine underneath the open pit at the Cavanacaw mine in Northern Ireland.

Auhua Clean Energy, down 14%. Chairman David Sumner has resigned due to "increasing demands on his time from his other business commitments", the company said. Raphael Tham has assumed the role of non-executive chairman. Tham was previously vice-chairman.
----------

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.